Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Predictive Oncology Inc. Director's Dealing 2012

May 29, 2012

35106_dirs_2012-05-29_cd4ef005-a648-4685-a354-2529894d7f01.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioDrain Medical, Inc. (BIOR)
CIK: 0001446159
Period of Report: 2012-05-11

Reporting Person: Ruwe Chad A. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-05-11 Common Stock par value $.01 per share J 200000 $.01 Acquired 2632001 Direct
2012-05-11 Common Stock par value $.01 per share J 212963 $.01 Acquired 2844964 Direct

Footnotes

F1: Stock options for former employee as compensation expense

F2: Stock options for former employee as compensation expense